Oncomatryx, a biopharmaceutical company, completed the acquisition of Tube Pharmaceuticals, a German a biopharmaceutical firm. Financial terms were not disclosed. "This strategic agreement is a significant milestone for Oncomatryx. It consolidates our technological portfolio and our commitment to target the microenvironment of the most invasive tumors. In addition, bringing Dr. Richter's knowledge and experience into our team will open up even more possibilities in the design and development of novel ADCs," Laureano Simon, Oncomatryx Founder.